论文部分内容阅读
肝动脉栓塞术是对不能切除肝癌的主要治疗方法,作者组引起腹痛者占95.4%。作者对肝动脉栓塞术并用硬膜外麻醉22例(并用组)进行了研究,并与未并用者作了对照。关于疼痛程度可分为四等:Ⅰ.无痛者;Ⅱ.有疼痛,但不需镇痛剂;Ⅲ.有疼痛,必须给镇痛剂(Pentazocine);Ⅳ.疼痛,必须给麻醉药。栓塞疗法并用组Ⅰ.为45.4%;Ⅱ36.8%,Ⅲ18.2%。非并用组Ⅰ.为0%;Ⅱ.40.9%;Ⅲ.59.1%;Ⅳ.0%栓塞术后第3日,并用组Ⅰ.为54.6%;Ⅱ.9.1%;Ⅲ.31.8%;Ⅳ.4.5%。非并用组Ⅰ.0%;Ⅱ.4.6%;Ⅲ.54.5%Ⅳ.40.9%。可见并用组疼痛明显减轻。至术后第3日,镇痛剂给与次数仍以并用组为少。并用组的副
Transcatheter arterial embolization is the main treatment for unresectable liver cancer. The authors accounted for 95.4% of abdominal pain. The authors studied hepatic artery embolization and epidural anesthesia in 22 cases (combined group) and compared them with those who did not. The degree of pain can be divided into four categories: I. Painless; II. Pain, but no need for analgesics; III. Pain, Pentazocine must be given; IV. Pain, must be given anesthetic. Embolization therapies with group I. was 45.4%; II 36.8%, III 18.2%. Non-combined group I was 0%; II.40.9%; III.59.1%; IV.0% after embolization on the 3rd, and group I. was 54.6%; II.9.1%; III.31.8%; IV. 4.5%. Non-concurrent use group I.0%; II.4.6%; III.54.5% IV.40.9%. It can be seen that the combined use of pain is significantly reduced. On the third day after surgery, the number of analgesics was still less in the combined group. And vice versa